Inhibition of aldose reductase prevents angiogenesis in vitro and in vivo

Ravinder Tammali, Aramati B M Reddy, Satish Srivastava, Kota Ramana

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

We have recently shown that aldose reductase (AR, EC 1.1.1.21) a nicotinamide adenine dinucleotide phosphate-dependent aldo-keto reductase, known to be involved in oxidative stress-signaling, prevents human colon cancer cell growth in culture as well as in nude mice xeno-grafts. Inhibition of AR also prevents azoxymethane-induced aberrant crypt foci formation in mice. In order to understand the chemopreventive mechanism(s) of AR inhibition in colon cancer, we have investigated the role of AR in the mediation of angiogenic signals in vitro and in vivo models. Our results show that inhibition of AR significantly prevented the VEGF- and FGF-induced proliferation and expression of proliferative marker Ki67 in the human umbilical vein endothelial cells (HUVEC). Further, AR inhibition or ablation with siRNA prevented the VEGF- and FGF-induced invasion and migration in HUVEC. AR inhibition also prevented the VEGF- and FGF- induced secretion/expression of IL-6, MMP2, MMP9, ICAM, and VCAM. The anti-angiogenic feature of AR inhibition in HUVEC was associated with inactivation of PI3 K/AKT and NF-κB (p65) and suppression of VEGF receptor 2 protein levels. Most importantly, matrigel plug model of angiogenesis in rats showed that inhibition of AR prevented infiltration of blood cells, invasion, migration and formation of capillary like structures, and expression of blood vessels markers CD31 and vWF. Thus, our results demonstrate that AR inhibitors could be novel agents to prevent angiogenesis.

Original languageEnglish (US)
Pages (from-to)209-221
Number of pages13
JournalAngiogenesis
Volume14
Issue number2
DOIs
StatePublished - May 2011

Fingerprint

Aldehyde Reductase
Endothelial cells
Human Umbilical Vein Endothelial Cells
Vascular Endothelial Growth Factor A
Colonic Neoplasms
Aberrant Crypt Foci
Azoxymethane
Vascular Endothelial Growth Factor Receptor
Oxidative stress
Blood vessels
Cell growth
Ablation
NADP
Cell culture
Infiltration
Nude Mice
Grafts
Small Interfering RNA
Cell Movement
Blood Vessels

Keywords

  • Aldose reductase
  • Angiogenesis
  • Cancer and inflammation
  • Endothelial cells

ASJC Scopus subject areas

  • Cancer Research
  • Physiology
  • Clinical Biochemistry

Cite this

Inhibition of aldose reductase prevents angiogenesis in vitro and in vivo. / Tammali, Ravinder; Reddy, Aramati B M; Srivastava, Satish; Ramana, Kota.

In: Angiogenesis, Vol. 14, No. 2, 05.2011, p. 209-221.

Research output: Contribution to journalArticle

Tammali, Ravinder ; Reddy, Aramati B M ; Srivastava, Satish ; Ramana, Kota. / Inhibition of aldose reductase prevents angiogenesis in vitro and in vivo. In: Angiogenesis. 2011 ; Vol. 14, No. 2. pp. 209-221.
@article{b7053bc5caf54435809a7903baa32189,
title = "Inhibition of aldose reductase prevents angiogenesis in vitro and in vivo",
abstract = "We have recently shown that aldose reductase (AR, EC 1.1.1.21) a nicotinamide adenine dinucleotide phosphate-dependent aldo-keto reductase, known to be involved in oxidative stress-signaling, prevents human colon cancer cell growth in culture as well as in nude mice xeno-grafts. Inhibition of AR also prevents azoxymethane-induced aberrant crypt foci formation in mice. In order to understand the chemopreventive mechanism(s) of AR inhibition in colon cancer, we have investigated the role of AR in the mediation of angiogenic signals in vitro and in vivo models. Our results show that inhibition of AR significantly prevented the VEGF- and FGF-induced proliferation and expression of proliferative marker Ki67 in the human umbilical vein endothelial cells (HUVEC). Further, AR inhibition or ablation with siRNA prevented the VEGF- and FGF-induced invasion and migration in HUVEC. AR inhibition also prevented the VEGF- and FGF- induced secretion/expression of IL-6, MMP2, MMP9, ICAM, and VCAM. The anti-angiogenic feature of AR inhibition in HUVEC was associated with inactivation of PI3 K/AKT and NF-κB (p65) and suppression of VEGF receptor 2 protein levels. Most importantly, matrigel plug model of angiogenesis in rats showed that inhibition of AR prevented infiltration of blood cells, invasion, migration and formation of capillary like structures, and expression of blood vessels markers CD31 and vWF. Thus, our results demonstrate that AR inhibitors could be novel agents to prevent angiogenesis.",
keywords = "Aldose reductase, Angiogenesis, Cancer and inflammation, Endothelial cells",
author = "Ravinder Tammali and Reddy, {Aramati B M} and Satish Srivastava and Kota Ramana",
year = "2011",
month = "5",
doi = "10.1007/s10456-011-9206-4",
language = "English (US)",
volume = "14",
pages = "209--221",
journal = "Angiogenesis",
issn = "0969-6970",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - Inhibition of aldose reductase prevents angiogenesis in vitro and in vivo

AU - Tammali, Ravinder

AU - Reddy, Aramati B M

AU - Srivastava, Satish

AU - Ramana, Kota

PY - 2011/5

Y1 - 2011/5

N2 - We have recently shown that aldose reductase (AR, EC 1.1.1.21) a nicotinamide adenine dinucleotide phosphate-dependent aldo-keto reductase, known to be involved in oxidative stress-signaling, prevents human colon cancer cell growth in culture as well as in nude mice xeno-grafts. Inhibition of AR also prevents azoxymethane-induced aberrant crypt foci formation in mice. In order to understand the chemopreventive mechanism(s) of AR inhibition in colon cancer, we have investigated the role of AR in the mediation of angiogenic signals in vitro and in vivo models. Our results show that inhibition of AR significantly prevented the VEGF- and FGF-induced proliferation and expression of proliferative marker Ki67 in the human umbilical vein endothelial cells (HUVEC). Further, AR inhibition or ablation with siRNA prevented the VEGF- and FGF-induced invasion and migration in HUVEC. AR inhibition also prevented the VEGF- and FGF- induced secretion/expression of IL-6, MMP2, MMP9, ICAM, and VCAM. The anti-angiogenic feature of AR inhibition in HUVEC was associated with inactivation of PI3 K/AKT and NF-κB (p65) and suppression of VEGF receptor 2 protein levels. Most importantly, matrigel plug model of angiogenesis in rats showed that inhibition of AR prevented infiltration of blood cells, invasion, migration and formation of capillary like structures, and expression of blood vessels markers CD31 and vWF. Thus, our results demonstrate that AR inhibitors could be novel agents to prevent angiogenesis.

AB - We have recently shown that aldose reductase (AR, EC 1.1.1.21) a nicotinamide adenine dinucleotide phosphate-dependent aldo-keto reductase, known to be involved in oxidative stress-signaling, prevents human colon cancer cell growth in culture as well as in nude mice xeno-grafts. Inhibition of AR also prevents azoxymethane-induced aberrant crypt foci formation in mice. In order to understand the chemopreventive mechanism(s) of AR inhibition in colon cancer, we have investigated the role of AR in the mediation of angiogenic signals in vitro and in vivo models. Our results show that inhibition of AR significantly prevented the VEGF- and FGF-induced proliferation and expression of proliferative marker Ki67 in the human umbilical vein endothelial cells (HUVEC). Further, AR inhibition or ablation with siRNA prevented the VEGF- and FGF-induced invasion and migration in HUVEC. AR inhibition also prevented the VEGF- and FGF- induced secretion/expression of IL-6, MMP2, MMP9, ICAM, and VCAM. The anti-angiogenic feature of AR inhibition in HUVEC was associated with inactivation of PI3 K/AKT and NF-κB (p65) and suppression of VEGF receptor 2 protein levels. Most importantly, matrigel plug model of angiogenesis in rats showed that inhibition of AR prevented infiltration of blood cells, invasion, migration and formation of capillary like structures, and expression of blood vessels markers CD31 and vWF. Thus, our results demonstrate that AR inhibitors could be novel agents to prevent angiogenesis.

KW - Aldose reductase

KW - Angiogenesis

KW - Cancer and inflammation

KW - Endothelial cells

UR - http://www.scopus.com/inward/record.url?scp=79959949384&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959949384&partnerID=8YFLogxK

U2 - 10.1007/s10456-011-9206-4

DO - 10.1007/s10456-011-9206-4

M3 - Article

VL - 14

SP - 209

EP - 221

JO - Angiogenesis

JF - Angiogenesis

SN - 0969-6970

IS - 2

ER -